Certificate number:RU.77.99.88.003.Е.005931.04.15
Date of registration and renewal:24.04.2015
Dosage form: & nbspCapsules of 0.3 g, tablets weighing 0.3 g, 0.5 g.
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp BAD-sources of vitamin-mineral complexes Supplements that promote the normalization of peripheral (capillary) blood circulation, incl. cerebral BAA sources of antioxidant substances and substances that affect energy metabolism
Composition: & nbspFormulation (tablet), lactose, premix vitamin standardized composition (vitamin E, C and beta-carotene), an extract of bilberry fruit, the organic zinc (glycinate, zinc), bioflavonoid complex (dihydroquercetin), hyaluronic acid (sodium hyaluronate), the flowing agent ( aerosil).

Composition (capsule) lactose premix vitamin standardized composition (vitamin E, C and beta-carotene), an extract of bilberry fruit, the organic zinc (glycinate, zinc), bioflavonoid complex (dihydroquercetin), hyaluronic acid (sodium hyaluronate), the flowing agent ( aerosil), capsule (gelatin).
Scope: & nbspDTo implement the public as a biologically active food additive - additional source of vitamins E, C, zinc, a source of beta-carotene, dihydroquercetin, hyaluronic acid containing anthocyanins.
Suggested Usage: & nbspAT1 tablet or 1 capsule 2 times a day with meals. Duration of admission 4 weeks. Break between courses for 4 weeks.
Contraindications:ANDndividualnaya intolerance of components of dietary supplements, pregnancy, breastfeeding.
Special instructions: Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions:Store in a dry place, protected from light, out of reach of children, at a temperature not exceeding 25 ° C.
Research protocols:ATreplacing the certificate of state registration No. RU.77.99.32.003.Е.002863.02.15 of 10.02.2015, expert opinion of the Research Institute of Nutrition of RAMS № 72 / Э-2953 / б-04 of 28.10.2004; the protocol of the Center for Analysis of the Quality of Biotechnology Products and BAD OOO BITEX № 827/1557 of 24.11.2014.
Recipient:Alina Pharma, OOOAlina Pharma, OOO Russian Federation
Information update date: & nbsp21.06.2016
Instructions
Up